TerminatedNCT00063362
Combination Therapy for the Treatment of Bipolarity
Medication studyAges 16+
Understand this study
Who could participate?
This study is for people with bipolarity. Listed age limits: from 16 years. Other eligibility criteria apply.
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateFebruary 2002
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 49
- Sponsor
- University Hospitals Cleveland Medical Center
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- Not clearly listed
- Age range
- Over 16 Years
- Official registry ID
- NCT00063362
- Official title
Show the full official title
Combination Therapy in Bipolar Rapid Cycling
Recruitment & locations
TerminatedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Locations not listed
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University Hospitals Cleveland Medical Center, a university.
Does this study involve medication?
Yes. The study involves medication, including lithium, lamotrigine, Divalproex and Placebo.
Who can participate?
This study is for people with bipolarity. Listed age limits: from 16 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as terminated.
